Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignancies, Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableAvailableNCT06872489
What this trial is testing

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Who this might be right for
Neuroblastoma in ChildrenNeuroblastoma, Recurrent, RefractoryAdvanced Cancer+7 more
Second Life Therapeutics
Early research (Phase 1)Study completedNCT01933568
What this trial is testing

Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm.

Who this might be right for
Inoperable Locally Advanced Non Small Cell Lung Cancer
The Netherlands Cancer Institute 15
Post-approval studies (Phase 4)Study completedNCT01196078
What this trial is testing

Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 114
Large-scale testing (Phase 3)Study completedNCT00931008
What this trial is testing

Study to Evaluate SID 530 Compared to Taxotere

Who this might be right for
Non-Small Cell Lung Cancer
SK Chemicals Co., Ltd. 42
Testing effectiveness (Phase 2)Looking for participantsNCT06667908
What this trial is testing

JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Johnson & Johnson Enterprise Innovation Inc. 130
Large-scale testing (Phase 3)Study completedNCT02272413
What this trial is testing

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 671
Testing effectiveness (Phase 2)Ended earlyNCT03050060
What this trial is testing

Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer

Who this might be right for
Metastatic Kidney CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Cutaneous Melanoma AJCC v6 and v7+2 more
University of Washington 21
Early research (Phase 1)Not Yet RecruitingNCT06823258
What this trial is testing

Pharmacokinetic Study of HS-10365 Capsule in Subjects with Hepatic Impairment and Normal Hepatic Function

Who this might be right for
NSCLC (advanced Non-small Cell Lung Cancer)
Jiangsu Hansoh Pharmaceutical Co., Ltd. 32
Early research (Phase 1)Active Not RecruitingNCT03401385
What this trial is testing

First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)

Who this might be right for
Hormone Receptor Positive Breast CancerTriple Negative Breast CancerNon-small Cell Lung Cancer
Daiichi Sankyo Co., Ltd. 890
Testing effectiveness (Phase 2)Study completedNCT04144608
What this trial is testing

Toripalimab Combined With Double Platinum-based Chemotherapy for Initially Unresectable NSCLC

Who this might be right for
Advanced Non Small Cell Lung Cancer
Yongchang Zhang 40
Testing effectiveness (Phase 2)Ended earlyNCT06171789
What this trial is testing

PRO1107 in Patients With Advanced Solid Tumors

Who this might be right for
Endometrial CancerOvarian CancerTriple Negative Breast Cancer+3 more
Genmab 33
Early research (Phase 1)Study completedNCT01005797
What this trial is testing

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

Who this might be right for
Renal CancerNon Small Cell Lung Cancer (NSCLC)Soft Tissue Sarcoma
Medical University of South Carolina 38
Testing effectiveness (Phase 2)Study completedNCT04258033
What this trial is testing

PLB1001 in Non-small Cell Lung Cancer With c-Met Dysregulation(KUNPENG)

Who this might be right for
Non-small Cell Lung Cancer
Beijing Pearl Biotechnology Limited Liability Company 145
Testing effectiveness (Phase 2)Study completedNCT00615758
What this trial is testing

Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 50
Testing effectiveness (Phase 2)Study completedNCT00425191
What this trial is testing

Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.

Who this might be right for
Non-small Cell Lung Cancer
Sanofi 165
Early research (Phase 1)Active Not RecruitingNCT04526691
What this trial is testing

Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)

Who this might be right for
Advanced or Metastatic NSCLC
Daiichi Sankyo 145
Very early researchEnded earlyNCT03454243
What this trial is testing

Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Hoffmann-La Roche 1
Early research (Phase 1)Ended earlyNCT04795713
What this trial is testing

Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1

Who this might be right for
Advanced Solid TumorNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck
Molecular Templates, Inc. 64
Testing effectiveness (Phase 2)Study completedNCT00826449
What this trial is testing

Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-Small Cell Lung Cancer
M.D. Anderson Cancer Center 53
Not applicableStudy completedNCT01597258
What this trial is testing

Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)

Who this might be right for
Non-small Cell Lung Cancer
Pfizer 2,029
Next Page